Therapeutic challenges in hepatitis C-infected injection drug using patients
<p>Abstract</p> <p>Hepatitis C Viral (HCV) infection in the injection drug user (IDU) population is a major medical concern. Concurrent substance abuse, co-morbid mental health conditions, poor socioeconomic status and a complex treatment protocol that is often incompatible with th...
Saved in:
Main Authors: | Cooper Curtis L (Author), Mills Edward J (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2006-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hepatitis C and Injection Drug Use: Testing and Linkage to Care
by: Marie Sutton, et al.
Published: (2016) -
Emergent predictors of hepatitis C infection among non-injection drug users
by: Sheila A. Teles, et al.
Published: (2018) -
Injection Drug use and Hepatitis C: Interventions in Behavioral Health Settings
by: Marie Sutton
Published: (2017) -
O13 Efficacy and safety of sofosbuvir/velpatasvir in people with chronic hepatitis C virus infection and recent injecting drug use: the SIMPLIFY study
by: J. Grebely, et al.
Published: (2017) -
Successes and challenges of best practice alerts to identify and engage individuals living with hepatitis C virus
by: Saniya Tandon, et al.
Published: (2024)